At OncoStem, we develop innovative prognostic tests that assess aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. Since 2011, our vision is to empower the doctors with evidence-based treatment plans with our smart prognostic tests. These actionable tests help the physicians in formulating a customized treatment plan by understanding the tumour biology. Robust research is ongoing in our laboratory to develop novel tests for other cancers.
What oncologists and cancer patients are saying about CanAssist Breast